These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 15368170)
21. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course. Cortez-Pinto H; Camilo ME Best Pract Res Clin Gastroenterol; 2004 Dec; 18(6):1089-104. PubMed ID: 15561640 [TBL] [Abstract][Full Text] [Related]
22. [Alcoholic and non-alcoholic fatty liver hepatitis. When is abstaining from alcohol enough, when do steroids help?]. Berghaus TM; Beuers U MMW Fortschr Med; 2001 Jul; 143(26-27):28-32. PubMed ID: 11481912 [TBL] [Abstract][Full Text] [Related]
23. [Alcoholic and nonalcoholic steatohepatitis: the same disease! II. Management]. Spahr L; Hadengue A Rev Med Suisse; 2005 Sep; 1(31):2032-4. PubMed ID: 16212005 [TBL] [Abstract][Full Text] [Related]
24. [Nonalcoholic steatohepatitis: a clinicopathological analysis of liver biopsy in 32 cases]. Meng JR; Zheng RD; Zhang MF; Guo YH; Lin MZ; Dai TJ Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):339-41. PubMed ID: 16546742 [TBL] [Abstract][Full Text] [Related]
25. [Alcoholic and non-alcoholic steatohepatitis: who is affected and what can we do for them?]. Gallego-Durán R; Ampuero J; Funuyet J; Romero-Gómez M Gastroenterol Hepatol; 2013 Nov; 36(9):587-96. PubMed ID: 24011648 [TBL] [Abstract][Full Text] [Related]
26. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated? Helling TS; Helzberg JH; Nachnani JS; Gurram K Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970 [TBL] [Abstract][Full Text] [Related]
31. Medical treatment of non-alcoholic steatohepatitis. Kadayifci A; Merriman RB; Bass NM Clin Liver Dis; 2007 Feb; 11(1):119-40, ix. PubMed ID: 17544975 [TBL] [Abstract][Full Text] [Related]
32. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity. Stratopoulos C; Papakonstantinou A; Terzis I; Spiliadi C; Dimitriades G; Komesidou V; Kitsanta P; Argyrakos T; Hadjiyannakis E Obes Surg; 2005 Sep; 15(8):1154-60. PubMed ID: 16197789 [TBL] [Abstract][Full Text] [Related]
33. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy. Javor ED; Ghany MG; Cochran EK; Oral EA; DePaoli AM; Premkumar A; Kleiner DE; Gorden P Hepatology; 2005 Apr; 41(4):753-60. PubMed ID: 15791619 [TBL] [Abstract][Full Text] [Related]
34. The use of protein tyrosine phosphatase 1B and insulin receptor immunostains to differentiate nonalcoholic from alcoholic steatohepatitis in liver biopsy specimens. Sanderson SO; Smyrk TC Am J Clin Pathol; 2005 Apr; 123(4):503-9. PubMed ID: 15743753 [TBL] [Abstract][Full Text] [Related]
35. Nutrition in pathophysiology and treatment of nonalcoholic fatty liver disease. Moschen AR; Tilg H Curr Opin Clin Nutr Metab Care; 2008 Sep; 11(5):620-5. PubMed ID: 18685459 [TBL] [Abstract][Full Text] [Related]